Clinical trials for preventative HIV gel

By Bizclik Editor

 

Scientists in South Africa are holding clinical trials to test a gel they believe could reduce the risk of women being infected with HIV.

The gel is being tested at seven centres and according to Professor Helen Rees, Executive Director of the Wits Reproductive Health and HIV Institute, is the first South African team of scientists to head a multi-site trial.

Previously, multi-site trials were led by international scientists working with local peers.

 

READ MORE FROM THE WDM CONTENT NETWORK:

To read the latest edition of African Business Review, click here.

 

"The planning for the Facts study is well under way and we hope to be in the field by August," said Rees.

The Tenofovir vaginal gel is seen as a positive breakthrough for HIV prevention. It proved 39 percent effective at protecting young women from HIV and halved the risk of Herpes HSV-2, according to the Caprisa 004 study in KwaZulu-Natal.

The Facts study aims to confirm these results.

Share

Featured Articles

Meet the COO: Brook Sims of MAC Diversity Recruiters

Passionate about helping others find their voice, diversity leader and COO Brook Sims talks powerful leadership, diverse teams and being a change agent

Best business books to improve leadership strategy

From strategic guides to inspiring CEO memoirs, these new books dish up plenty of principles, strategies, and anecdotes to help you become a better leader

Shoplazza founder and CEO Jeff Li, ex Baidu, on leadership

Named in Fortune China’s 40 under 40 for 2022, former Baidu head Jeff Li is the entrepreneurial founder and CEO of ecommerce platform Shoplazza

The office shifts to new way of working – workplace special

Leadership & Strategy

Trailblazer: Clorox's DEI leader Shanique Bonelli-Moore

Sustainability

The inspirational CEO story – Dean Forbes of Forterro

Leadership & Strategy